Luteolin as a therapeutic option for multiple sclerosis.

Theoharides, Theoharis C.
2009

Abstract: Multiple sclerosis (MS) remains without an effective treatment in spite of intense research efforts. Interferon-beta (IFN-β) reduces duration and severity of symptoms in many relapsing-remitting MS patients, but its mechanism of action is still not well understood. Moreover, IFN-β and other available treatments must be given par... read more

Permanent URL
http://hdl.handle.net/10427/010118
Original publication
Theoharides, Theoharis, "Luteolin as a therapeutic option for multiple sclerosis." Journal of Neuroinflammation 6, no. 1 (12, 2009): 1-3.
ID: tufts:17500
To Cite: DCA Citation Guide
Usage: Detailed Rights